Frédéric Franceschi1, Linda Koutbi2, Edouard Gitenay2, Jérome Hourdain2, Baptiste Maille2, Lory Trévisan2, Jean-Claude Deharo2. 1. From the APHM, Department of Cardiology, Timone University Hospital, Marseille, France (F.F., L.K., E.G., J.H., B.M., L.T., J.-C.D.) and UMR MD2, Aix, Marseille University (AMU), Marseille, France (F.F., J.-C.D.). frederic.franceschi@ap-hm.fr. 2. From the APHM, Department of Cardiology, Timone University Hospital, Marseille, France (F.F., L.K., E.G., J.H., B.M., L.T., J.-C.D.) and UMR MD2, Aix, Marseille University (AMU), Marseille, France (F.F., J.-C.D.).
Abstract
BACKGROUND: Electromyography-guided phrenic nerve (PN) monitoring using a catheter positioned in a hepatic vein can aid in preventing phrenic nerve palsy (PNP) during cryoballoon ablation for atrial fibrillation. We wanted to evaluate the feasibility and efficacy of PN monitoring during procedures using second-generation cryoballoons. METHODS AND RESULTS: This study included 140 patients (43 women) in whom pulmonary vein isolation was performed using a second-generation cryoballoon. Electromyography-guided PN monitoring was performed by pacing the right PN at 60 per minute and recording diaphragmatic compound motor action potential (CMAP) via a quadripolar catheter positioned in a hepatic vein. If a 30% decrease in CMAP amplitude was observed, cryoapplication was discontinued with forced deflation to avoid a PNP. Monitoring was unfeasible in 8 of 140 patients (5.7%), PNP occurred in 1. Stable CMAP amplitudes were achieved before ablation in 132 of 140 patients (94.3%). In 18 of 132 patients (13.6%), a 30% decrease in CMAP amplitude occurred and cryoablation was discontinued. Each time, recovery of CMAP amplitude took <60 s. In 9 of 18 cases, a second cryoapplication in the same pulmonary vein was safely performed. We observed no PNP or complication related to electromyography-guided PN monitoring. CONCLUSIONS: Electromyography-guided PN monitoring using a catheter positioned in a hepatic vein seems feasible and effective to prevent PNP during cryoballoon ablation using second-generation cryoballoon.
BACKGROUND: Electromyography-guided phrenic nerve (PN) monitoring using a catheter positioned in a hepatic vein can aid in preventing phrenic nerve palsy (PNP) during cryoballoon ablation for atrial fibrillation. We wanted to evaluate the feasibility and efficacy of PN monitoring during procedures using second-generation cryoballoons. METHODS AND RESULTS: This study included 140 patients (43 women) in whom pulmonary vein isolation was performed using a second-generation cryoballoon. Electromyography-guided PN monitoring was performed by pacing the right PN at 60 per minute and recording diaphragmatic compound motor action potential (CMAP) via a quadripolar catheter positioned in a hepatic vein. If a 30% decrease in CMAP amplitude was observed, cryoapplication was discontinued with forced deflation to avoid a PNP. Monitoring was unfeasible in 8 of 140 patients (5.7%), PNP occurred in 1. Stable CMAP amplitudes were achieved before ablation in 132 of 140 patients (94.3%). In 18 of 132 patients (13.6%), a 30% decrease in CMAP amplitude occurred and cryoablation was discontinued. Each time, recovery of CMAP amplitude took <60 s. In 9 of 18 cases, a second cryoapplication in the same pulmonary vein was safely performed. We observed no PNP or complication related to electromyography-guided PN monitoring. CONCLUSIONS: Electromyography-guided PN monitoring using a catheter positioned in a hepatic vein seems feasible and effective to prevent PNP during cryoballoon ablation using second-generation cryoballoon.
Authors: Christian-H Heeger; Erik Wissner; Peter Wohlmuth; Shibu Mathew; Kentaro Hayashi; Christian Sohns; Bruno Reißmann; Christine Lemes; Tilman Maurer; Ardan M Saguner; Francesco Santoro; Johannes Riedl; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Clin Res Cardiol Date: 2016-04-16 Impact factor: 5.460
Authors: Omar Anwar; Melanie A Gunawardene; Jannis Dickow; Katharina Scherschel; Christiane Jungen; Paula Münkler; Christian Eickholt; Stephan Willems; Nele Gessler; Christian Meyer Journal: PLoS One Date: 2020-06-25 Impact factor: 3.240
Authors: Emily N Guhl; Donald Siddoway; Evan Adelstein; Raveen Bazaz; George S Mendenhall; Jan Nemec; Samir Saba; David Schwartzman; Andrew Voigt; Norman C Wang; Sandeep K Jain Journal: J Am Heart Assoc Date: 2016-07-21 Impact factor: 5.501